Abwaab is an online learning platform that allows secondary-school students to learn at their own pace, test themselves and get ahead with our expert tutors anytime and anywhere. By offering short, engaging video lessons, visualized learning journeys, continuous assessment and performance analytics, we are changing the way students learn outside the classroom.
Bosta provides an on-demand courier app with a B2C focus, allowing users to send parcels to their customers. The platform connects its users to couriers and allows them to monitor the status of the delivery of the package. By leveraging cutting-edge technology and streamlining operations, it is committed to disrupting the logistics industry.
Mamo transforms businesses by helping them consolidate payment collection, corporate cards, and expense management into one beautiful, intuitive platform. Over 1,000 companies have used Mamo to improve revenue collection, control spend, reduce costs and automate financial operations.
MaxAB is a B2B e-commerce platform that connects food and grocery retailers to suppliers in the most under-served geographies. We are Re-engineering the informal grocery and food market using empowering technologies and innovative supply chains that is designed to fit the needs of retailers in the areas we serve. We are on a mission to empower the retailers, by availing access to a wide range of products, premium service and operational support. Our technology enabled supply chain is helping put the correct amount of food at the right place at the right time. The company was founded in 2018 and is headquartered in Cairo, Egypt.
mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly to consumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices. The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013.